Background and Objectives: A multicenter survey was carried out in 11
Finnish hospitals to determine the prevailing transfusion practices in
orthopedic surgery. Materials and Methods: The records of 1,161 patie
nts who had undergone primary total hip (THR) or knee replacement (TKR
) were reviewed. Results: Allogeneic red cells (RBC) were administered
to 92% of the THR patients and to 84% of the patients undergoing TKR.
Significant interhospital variation in RBC transfusion, from 2.4 to 4
.1 units per patient in THR and from 1.8 to 2.8 units in TKR, was dete
cted after adjustment for clinical and laboratory findings. Conclusion
: The use of RBCs in orthopedic surgery was generous compared with rep
orts from other European countries and the US. Each hospital's individ
ual transfusion policy seemed to be a strong determinant of allogeneic
blood use.